ADAR1 Capital Management »

Pono Cap Two shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Pono Cap Two (PTWOW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Pono Cap Two

Tip: Access up to 7 years of quarterly data

All positions including Pono Cap Two held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pono Cap Two by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $558 20k 0.03

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Pono Cap Two

Polar Securities
Context Capital Management
Schechter Investment Advisors
CNH Partners
MMCAP International Inc. SPC
Wolverine Asset Management
Cubist Systematic Strategies
Weiss Asset Management LP[1
Hudson Bay Capital Management
Saba Capital Management
Cable Car Capital
Aristeia Capital
D. E. Shaw & Co
Walleye Trading Advisors
Rpo

View all funds holding Pono Cap Two